These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5469056)

  • 21. Serum-monoamine-oxidase levels during levodopa therapy.
    Tryding N; Tufvesson G; Nilsson S
    Lancet; 1971 Apr; 1(7704):859. PubMed ID: 4102546
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple primary melanoma following administration of levodopa.
    Skibba JL; Pinckley J; Gilbert EF; Johnson RO
    Arch Pathol; 1972 Jun; 93(6):556-61. PubMed ID: 5025039
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment failures with levodopa in Parkinsonism.
    Lieberman AN; Goodgold AL; Goldstein M
    Neurology; 1972 Nov; 22(11):1205-10. PubMed ID: 4673563
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term treatment of Parkinson's disease with levodopa.
    Campbell JB
    Neurology; 1970 Dec; 20(12):Suppl:18-22. PubMed ID: 4991656
    [No Abstract]   [Full Text] [Related]  

  • 26. Manic response to levodopa therapy. Report of a case.
    Ryback RS; Schwab RS
    N Engl J Med; 1971 Sep; 285(14):788-9. PubMed ID: 5567266
    [No Abstract]   [Full Text] [Related]  

  • 27. The Eaton Collaborative Study of levodopa therapy in parkinsonism: a summary.
    Keenan RE
    Neurology; 1970 Dec; 20(12):46-59. PubMed ID: 5531294
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE
    JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract]   [Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations].
    Sigwald J
    Nouv Presse Med; 1972 Mar; 1(10):679-82. PubMed ID: 5022921
    [No Abstract]   [Full Text] [Related]  

  • 31. Levodopa and induced-pain response. A study of patients with Parkinsonian and pain syndromes.
    Battista AF; Wolff BB
    Arch Intern Med; 1973 Jul; 132(1):70-4. PubMed ID: 4716428
    [No Abstract]   [Full Text] [Related]  

  • 32. More on levodopa--implications for adrenal function.
    Greenberg SR
    N Engl J Med; 1972 Feb; 286(7):375-6. PubMed ID: 4332797
    [No Abstract]   [Full Text] [Related]  

  • 33. Levodopa and physical therapy in treatment of patients with Parkinson's disease.
    Stern PH; McDowell F; Miller JM; Robinson M
    Arch Phys Med Rehabil; 1970 May; 51(5):273-7. PubMed ID: 5420013
    [No Abstract]   [Full Text] [Related]  

  • 34. Levodopa.
    Lancet; 1971 Sep; 2(7723):533. PubMed ID: 4105672
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmunity in patients treated with levodopa.
    Cotzias GC; Papavasiliou PS
    JAMA; 1969 Feb; 207(7):1353-4. PubMed ID: 5304532
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical pharmacology of levodopa.
    Morgan JP; Bianchine JR
    Ration Drug Ther; 1971 Jan; 5(1):1-8. PubMed ID: 5162935
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 38. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 39. New drugs--No. 4. Levodopa.
    J Ir Med Assoc; 1973 May; 66(10):273-4. PubMed ID: 4720104
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of L-DOPA in the therapy of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G
    Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.